JUDY LEGASPI: Open Payments
NPI 1548286545 · MORTON GROVE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,904 in 93 payments from 9 companies in 2025. Trend: 2023 $1,941 · 2024 $2,585 · 2025 $1,904
Food & beverage: $1,904
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 19 | $496 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $299 |
| E.R. Squibb & Sons, L.L.C. | 14 | $279 |
| Otsuka America Pharmaceutical, Inc. | 13 | $247 |
| Neurocrine BioSciences, Inc. | 10 | $176 |
| Teva Pharmaceuticals USA, Inc. | 13 | $165 |
| Janssen Pharmaceuticals, Inc | 7 | $122 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| ABBVIE INC. | 2 | $50 |
Products named: ARISTADA, CAPLYTA, COBENFY, REXULTI, INGREZZA, INVEGA SUSTENNA, LYBALVI, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
